118 related articles for article (PubMed ID: 21243595)
21. Cisapride stimulates small intestinal motility and relieves constipation in myelopathy due to cervical spinal stenosis: case report.
Hellström PM; Aly A; Johansson C
Paraplegia; 1990 May; 28(4):261-4. PubMed ID: 2235032
[TBL] [Abstract][Full Text] [Related]
22. Clinical trial: the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation--a 12-week, randomized, double-blind, placebo-controlled study.
Quigley EM; Vandeplassche L; Kerstens R; Ausma J
Aliment Pharmacol Ther; 2009 Feb; 29(3):315-28. PubMed ID: 19035970
[TBL] [Abstract][Full Text] [Related]
23. [Treatment with bisacodyl, picosulfate and prokinetics. Physiopathology and diagnosis of constipation].
Müller-Lissner S
Pharm Unserer Zeit; 2008; 37(2):130-4. PubMed ID: 18293319
[No Abstract] [Full Text] [Related]
24. [Which forms of constipation could benefit from motility-active drugs?].
Müller-Lissner S
Z Gastroenterol; 1990 Apr; 28 Suppl 1():89-91; discussion 94-5. PubMed ID: 2192511
[No Abstract] [Full Text] [Related]
25. What role for prucalopride in constipation?
Drug Ther Bull; 2011 Aug; 49(8):93-6. PubMed ID: 21831905
[TBL] [Abstract][Full Text] [Related]
26. [Prucalopride - oral (Resolor)].
J Pharm Belg; 2010 Dec; (4):133-4. PubMed ID: 21294319
[No Abstract] [Full Text] [Related]
27. Prucalopride in a case of severe opioid induced constipation.
Dagtekin O
Minerva Anestesiol; 2012 Apr; 78(4):513-4. PubMed ID: 22310195
[No Abstract] [Full Text] [Related]
28. Balancing risks and benefits of prucalopride for the treatment of chronic constipation in Asians.
Morais SA; Ford AC
Neurogastroenterol Motil; 2013 Jan; 25(1):89. PubMed ID: 23279729
[No Abstract] [Full Text] [Related]
29. Neurological and psychiatric adverse events with prucalopride: case report and possible mechanisms.
Carnovale C; Pellegrino P; Perrone V; Antoniazzi S; Pozzi M; Nisic A; Clementi E; Radice S
J Clin Pharm Ther; 2013 Dec; 38(6):524-5. PubMed ID: 23889005
[TBL] [Abstract][Full Text] [Related]
30. If it is inert, why does it move?
Bassotti G
Neurogastroenterol Motil; 2004 Aug; 16(4):395-6. PubMed ID: 15305993
[No Abstract] [Full Text] [Related]
31. Role of prucalopride in treatment of chronic constipation and recurrent functional obstruction in a patient with steinert myotonic dystrophy.
Giglio MC; Luglio G; Tarquini R; Cerbone D; Bucci P; Bucci L
J Clin Gastroenterol; 2015 Jan; 49(1):85-6. PubMed ID: 24804990
[No Abstract] [Full Text] [Related]
32. Diarrhea and constipation: mechanism and treatment.
Manier JW
Semin Drug Treat; 1974; 3(4):321-9. PubMed ID: 4822254
[No Abstract] [Full Text] [Related]
33. Response to letter: Balancing risks and benefits of prucalopride for the treatment of chronic constipation in Asians.
Ke M; Zou D; Yuan Y; Li Y; Lin L; Hao J; Hou X; Kim HJ
Neurogastroenterol Motil; 2013 Jan; 25(1):90-1. PubMed ID: 23279730
[No Abstract] [Full Text] [Related]
34. [Colonic motility in humans. Recent physiological, pathophysiological and pharmacological data].
Jouët P; Coffin B; Cuillerier E; Soulé JC; Flourié B; Lémann M
Gastroenterol Clin Biol; 2000 Mar; 24(3):284-98. PubMed ID: 10804335
[No Abstract] [Full Text] [Related]
35. Dexpanthenol (Ro 01-4709) in the treatment of constipation.
Hanck AB; Goffin H
Acta Vitaminol Enzymol; 1982; 4(1-2):87-97. PubMed ID: 6751051
[TBL] [Abstract][Full Text] [Related]
36. Plecanatide (Trulance) for chronic idiopathic constipation.
Med Lett Drugs Ther; 2017 Apr; 59(1519):66-68. PubMed ID: 28419073
[No Abstract] [Full Text] [Related]
37. Effect of MKC-733, a 5-HT receptor partial agonist, on bowel motility and symptoms in subjects with constipation: an exploratory study.
Fujita T; Yokota S; Sawada M; Majima M; Ohtani Y; Kumagai Y
J Clin Pharm Ther; 2005 Dec; 30(6):611-22. PubMed ID: 16336295
[TBL] [Abstract][Full Text] [Related]
38. [Resotran. A new agent for the treatment of chronic constipation].
Perspect Infirm; 2012; 9(3):46. PubMed ID: 23451425
[No Abstract] [Full Text] [Related]
39. Prucalopride in clozapine-induced constipation.
Thomas N; Jain N; Connally F; Yeung JM; Pantelis C
Aust N Z J Psychiatry; 2018 Aug; 52(8):804. PubMed ID: 29749251
[No Abstract] [Full Text] [Related]
40. Translating 5-HT receptor pharmacology.
Sanger GJ
Neurogastroenterol Motil; 2009 Dec; 21(12):1235-8. PubMed ID: 19906028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
